Bonjesta

Medicinal product

(Invented) name

Bonjesta

Active substance (s)

Doksilamino-vandenilio sukcinatas/Piridoksino hidrochloridas

Strength

20 mg/20 mg

Pharmaceutical form

modifikuoto atpalaidavimo tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R06AA59, Doxylamine, combinations

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-08-28

Date of renewal

Documents

2813_Bonjesta 20mg20mg N10N20 tabletes Italija_PL.docx

2813_Bonjesta 20mg20mg N10N20 tabletes Italija_PZ.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Doksilamino-vandenilio sukcinatas	20 mg
Piridoksino hidrochloridas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
118361	104467	1104467	lizdinė plokštelė	N10		Receptinis	LT/L/25/2813/001	Netiekiama	-	-	No	-	-	Download
118362	104468	1104468	lizdinė plokštelė	N20		Receptinis	LT/L/25/2813/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-08-28	Registruotas